MATERIALS AND METHODS

Materials:
All chemical reagents were purchased from Millipore Sigma, unless otherwise specified. Biotin-16-aminoallyl-2′-deoxycytidine-5′-triphosphate was purchased from TriLink BioTechnologies, Inc. The hydrochloride salt of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide was purchased from Alfa Aesar. The hydrochloride salt of 2-aminoimidazole was purchased from Combi-Blocks, Inc. 2,2′-dipyridyl disulfide was purchased from ChemImpex International.
All enzymes and molecular biology reagents were purchased from New England Biolabs unless otherwise specified. Acid-phenol chloroform and SYBR TM Gold Nucleic Acid Gel Stain were purchased from ThermoFisher Scientific. 100% ethanol was purchased from Decon Laboratories, Inc. QIAquick PCR purification kits were purchased from Qiagen. The Sequagel-UreaGel concentrate and diluent system for denaturing 10% and 20%
polyacrylamide gels was purchased from National Diagnostics. A 0.5 M ethylenediaminetetraacetic acid (EDTA) stock solution was purchased from Molecular Biologicals International, Inc.
All nucleic acid oligonucleotides are listed in the Supplementary Table S1 . All oligonucleotides were purchased from Integrated DNA Technologies, except for LS3, which was synthesized in-house using standard RNA phosphoramidites purchased from BioAutomation.
Preparation of 2AI-activated oligos:
The biotinylated, 2AI-activated ligator LS1 used in the selection was prepared from the RNA oligomer LS3, which was converted to the 5′-phosphorimidazolide LS2 using triphenyl phosphine and 2,2′-dipyridyl disulfide as previously described (1) . A biotin-16-aminoallyl-2′-deoxycytidine nucleotide was added to the 3′ end of LS2 to generate LS1 in an enzymatic reaction containing 10 µM substrate LS2, 25 µM DNA template BT1, 200 µM biotin-16-aminoallyl-2′-deoxycytidine-5′-triphosphate, 100 units/mL of Therminator TM DNA polymerase, and 1x of the vendor-supplied ThermoPol â reaction buffer. The Therminator TM reaction was incubated at 95 °C for 2 min., 4 °C for 10 min., and 37 °C for 1 h. This reaction was subsequently diluted with an equal volume of 1 mM CaCl2 and digested with 50 units/mL DNase I for 30 min. at 37 °C. Then, the mixture was extracted with phenol/chloroform, ethanol precipitated, and purified by reverse phase analytical HPLC using a gradient of 98% to 75% 20 mM TEAB (triethylamine bicarbonate, pH 8) versus acetonitrile over 40 min. using procedures described previously (1) .
Fractions containing LS1 were flash frozen and lyophilized before determining purity by LC-MS. To prepare the 2-AI activated ligators LS2 and LS4 used in ligation assays, the RNA oligomers LS3 and LS5 were activated by incubating with 0.2 M 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (HCl salt) and 0.6 M 2-aminoimidazole (HCl salt, pH adjusted to 6) for 1-2 h at room temperature. The reaction mixtures were desalted and purified by HPLC as above. A similar approach was used for the other ligators used in this study.
In vitro selection:
The double-stranded DNA (dsDNA) library template was prepared in a 480 µL reverse transcription reaction containing 2.4 nmol DNA oligo SL1 and 4.8 nmol DNA oligo DS1 using ProtoScript ® II reverse transcriptase enzyme according to manufacturer recommendations. The dsDNA library was converted to the RNA library using HiScribe TM T7 polymerase in a 2.4 mL reaction incubated for 3 h at 37 °C. The T7 reaction was then digested by DNase I, extracted with phenol chloroform, ethanol-precipitated, and purified by 10% PAGE. The PAGE-purified T7 product RNA was then digested using the restriction enzyme Ava-II, which cleaves DNA/RNA hybrid duplexes to generate defined 3′ ends on the RNA strand with free hydroxyls groups (2). Ava-II digests were incubated for 10 h at 37 °C and contained 3.3 µM PAGE-purified T7 product, 10 µM DNA template AD1, 1x
buffer, and 5000 units/mL Ava-II enzyme. Digests were then treated with DNase I, extracted with phenol chloroform, ethanol precipitated, and PAGE purified.
To select for ligase activity, RNA pools were incubated at room temperature for 10-120 min. in reactions that contained 1 µM RNA library, Tween-20) for 15 min., twice with buffer C for 5 min., and three more times with buffer A. The magnetic beads were then suspended in 95% formamide containing 10 mM EDTA and heated for 6 min. at 65 °C to release the captured RNA. This sample was then diluted with 4.5 ´ volume of 300 mM sodium acetate with 100 ng / µL glycogen and ethanol-precipitated.
For rounds 1-3, ethanol-precipitated RNA was reverse transcribed in a reaction containing ProtoScript ® II reverse transcriptase and 10 µM DNA primer RT1 according to manufacturer recommendations. Reactions were incubated at 42 °C for 3 h, and then heat-denatured for 5 min. at 80 °C. The denatured reverse transcription reactions were then diluted 10 ´ in a PCR reaction containing Taq DNA polymerase, 0.5 µM DNA primer PCR1, and 0.5 µM DNA primer PCR2 using manufacturer recommendations. PCR reactions were first incubated at 95 °C for 2 min.;
then underwent 16 cycles of 94 °C for 30 s, 60 °C for 1 min., and 72 °C for 1 min.; and finally, 72 °C for 10 min.
For rounds 4-8, ethanol-precipitated RNA was reverse transcribed in reactions containing 10 µM DNA primer RT2. The reverse transcribed pool was then PCR amplified as described above for only 10 cycles, purified using a QIAquick spin column, and amplified another 8 cycles using PCR. These steps were undertaken to reduce PCR amplification by the reverse transcription primer RT2, which is contained in the heat-denatured reverse transcription reaction. QIAquick purified PCR reactions were then transcribed by T7 RNA polymerase, and the RNA digested by Ava-II as described above.
High throughput sequencing:
To prepare the selected pools for sequencing, adaptor sequences were introduced onto the dsDNA pools resulting from each round of selection using several rounds of PCR with different primer sets. First, a 100 µL PCR reaction containing 25 ng dsDNA PCR product with 0.5 µM DNA primer PS1 and 0.5 µM DNA primer PS2, was amplified by Taq DNA polymerase for 4 cycles as described above. The PCR product was purified using QIAquick PCR Purification Kit (Qiagen), and then further amplified for 7 cycles in a second PCR reaction containing 40 ng dsDNA, 0.5 µM DNA primer PS3, and 0.5 µM DNA primer PS4. The purified product of the second PCR reaction was amplified once again in a 50 µL reaction containing The PCR product was purified using a QIAquick PCR Purification Kit and then by agarose gel purification. The Ligation assays:
Ligation reactions contained 1 µM of the RNA pool or individual construct, 1.5 µM RNA template LT1, 2 µM ligator strand LS1 or LS2, 250 mM NaCl, 10 mM MgCl2, and 100 mM Tris pH 8. Reaction aliquots of 1.4 µL were quenched in 6 µL kill buffer (8 M urea, 100 mM Tris-Cl, 100 mM boric acid, 75 mM EDTA) and stored frozen on dry ice until analysis by 10% PAGE. After running samples for 35 min. at 30 W, gels were stained using SYBR TM Gold and imaged on an Amersham Typhoon RGB instrument (GE Healthcare). RNA bands were quantified with IQTL 8.1 software, and then normalized relative to sequence length. Kinetic analysis was performed by nonlinearly fitting the data using Prism7 software to the modified first order rate equation y = A(1 -e -kx ), where A represents the fraction of active complex, k is the first order rate constant, x is time, and y is the fraction of ligated product.
Individual ribozymes and truncated constructs were prepared by in vitro transcription of DNA template containing 5′ terminal 2′-O-methyl modifications to reduce transcriptional heterogeneity at the 3' end of the synthesized RNA (3). Modified DNA templates were generated by PCR amplification using primers unique for each sequence and truncation product. Primers for generating 5′ truncations (FT1-10), 3′ truncations (TT1-TT10), and full-length constructs (ME1-ME10) using this method are included in Supplementary Table S3 . One and two nucleotide 3′ truncations of RS1 ( DNA template, for 2 h at 37°C. The RNA was subsequently treated with DNase I, phenol-chloroform extracted, and PAGE-purified. Our initial examination of ligase activity in Figure 3 and S4 uses RNA prepared by Ava-II digestion as described above.
Determination of phosphodiester bond regiospecificity
Ligation reactions containing 10 pmol ribozyme, 10 pmol substrate oligo LS6, and 12 pmol of the DNA template LT2 were incubated for 2-6 h before DNase digestion to remove the template. Following phenolchloroform extraction, unreacted LS6 substrate was removed by 3-4 washes on a centrifugal 30 kDa molecular weight filter (EMD Millipore). The resulting concentrate was denatured by incubation at 95 °C for 6 minutes in the presence of 6 M urea and 1 mM EDTA, and then digested by RNase T1 for 24 h at 55 °C. These digestions were then extracted by phenol-chloroform and analyzed by 20% PAGE. To determine the sensitivity of this assay, a calibration curve was generated using a synthetic 17 nt RNA oligo standard to quantify the limit of detection in terms of pmol input RNA (Fig. S14) . We then quantified the 16 nt band intensities (corresponding to the RNase T1 digestion product of the 3′-5′ linked ligation product) for each of the reactions for RS1-RS10 and used these values to calculate pmol input RNA based upon the calibration curve. The sensitivity of our assay is then given by dividing the pmol limit of detection by the calculated pmol input RNA of the 16 nt digestion products. Multiplying this fraction by 100 gives the reported percentage value corresponding to the maximum amount of 2′-5′ linked ligation product possible in the sample without being detected in our assay.
Secondary structure determination by SHAPE
The secondary structure of RS1 was determined by adapting previously published RNA SHAPE protocols (4-6). The sequence used in the SHAPE experiments (5′-GGCCUUCGGGCCAAGGACAGCGGAAUGCUGC CAACCGUGCGGGCUAAUUGGCAGACUGAGCUCGCUGUCCUUUUUUGGCUAAGGUCGAUCCGGU UCGCCGGAUCCAAAUCGGGCUUCGGUCCGGUUC-3′) consists of the 5′ truncated form of RS1 (bold letters)
flanked by 5′ and 3′ SHAPE cassettes (italicized letters). The italicized, underlined letters correspond to the reverse transcription primer binding site. 100 pmol of this RNA sequence was folded under ligation conditions: 100 mM Tris-HCl (pH 8), 250 mM NaCl, 10 mM MgCl2 and divided into two tubes for SHAPE modification and control reactions. 5 µl 100 mM 1M7 (in DMSO) was used per modification reaction. Following modification, both +1M7
and -1M7 RNA were reverse transcribed using 40 pmol 5′ FAM-labeled primer (5′-FAM-GAACCGGACCGAAGC CCG-3′). Sequencing lanes were generated by incorporating ddNTPs into reverse transcription reactions with 30 pmol unmodified RNA and 25 pmol FAM-labeled primer. The quenched reactions were then analyzed by 10%
denaturing PAGE as described above. Normalized SHAPE reactivity was calculated by first excluding the most reactive nucleotide position and then dividing reactivities at each position by the average of the top 10% most reactive positions (4 most reactive positions in this case). These normalized SHAPE reactivities were used to constrain secondary structure prediction in the RNAStructure program (4). Cluster # Loop sequence variants of RS1 were prepared using ME1-A, ME1-C, and ME1-U, and used in combination with LS2, LS2-C, LS2-G, and LS2-U (Table S3 ). The template sequence was not changed in any of the reactions. The fraction of ligated product at 2 h was measured for the 16 different conditions and presented in a heat map. These results indicate that at least one intact base-pair is required for ligation; an AU or GU pair in the substrate-template duplex is sufficient to allow an AC mismatch in the primer-template duplex. Similarly, a GC pair in the primer-template duplex is sufficient to allow an CU (to some extent a UU) mismatch in the substrate-template duplex.
-CCTAGCTAGCGCTGACTAGGACAGATGAGCGGCGGAACCA-------------------------7 --AAAAGTTTCGCTGAATTGGACAGACCACCGCGTGAAGTGG------------------------61--------------AGTAAAGTTAATACTGACACGGAATCAGAGATTGCTAATT------------35------------AGTCCGTCTAAACGGTTATCGCGCGGAAGCGAGAGTAATT--------------16-----------TGATGAATCGGCATACGTGGGTCAGAGTCATAGTGCGACA---------------11-------------TTGGTGTAGAGCGCCAACTGGACAGACCTTACGG-AAACGG------------12--------------AAGCTCTCGCCAGCAAAAGAACAGACCGTCGAGGAAACGG------------38-------------ATAACTGTCGCCGTTTAATGGACAGACCAGTGCGG-AACGG------------51--------------CGGCTTTAGACCGCATCTGGACAGATCAACGCGGACTTGA------------45--------------GTCAGTCGTGAAACAATCGTACAGACGTTACCGGAAACCG------------43--------------AGTCATATTTACCAAGGAGGACAGACATACACGGAATCTG------------
63--------------GTTACCAAAACCGCAAAATGACAGACGTCACCGGAAGCCG------------14--------------AGAGCCTAGTCGCTAACCGGACAGACCTACACGGAATAGG------------8 --------------TCAGTCGGAGTACCAGAGCGATAGACGTCCCCGGAAGCCG------------49--------------TCAGCCGGAACAATAGAATGACAGACGTACGCGGAATACG------------56---------TCGTTCCACGCGGGATCCCTTTAGAGGGGCTACAAATGCC-----------------27-------GGTGACATTAAGCGGAATGCCTTAAGAGG-CGTACAAATAA------------------44---------TTCTTCCATGCGGTTTTCCTTAAGAGGAG-TACAAAACTAT----------------6 -----------AGCCACTGCGGAAGACCTTAAGAGGTGTAATTGCTCACCC---------------41----ACACAGTTGAGAGTGCGGAATTCCTTAAGAGGAGCCCCTT----------------------46-----------CCAGAACACGTCAACCCTGCCGAGGCTAAGGACATAAAAC---------------23-------TGTCGTAAACGGTGTACCCCAAGTGAAGGGGTTGTAAATC-------------------59--------GTAGTCAATGCCCAACCAACTCTGGCGGAATGGTAACTTA------------------22------------TCAGTGAGAATACAAGTGT-GGAGGCTAAGTGACTTAAACC-------------50------------TCAGGCATAGTAACCCAGTCGGAGGCTAAGGACG-TAAACC-------------
Other mismatch combinations at the ligation junction do not support ligation. Template sequences LT+1 through LT+8 can be found in Supplementary Table S3 . Table S1 . Parameters for each round of selection. Name  Type  Sequence  AD1  DNA  CGGTAGGTCCCTTAGCC  BT1  DNA  GTGCGGAATGCGGTGGTCC   DS1  DNA  TAATACGACTCACTATAGACTCACTGACACAGATCCACTCACGGAC  AGCG  FT1  DNA  TAATACGACTCACTATAGGGACAGCGGAATGCTGCCAA  FT2  DNA  TAATACGACTCACTATAGGGACAGCGCCTAGCTAGCG  FT3  DNA  TAATACGACTCACTATAGGGACAGCGTTAGTGAAATTGGTGCC  FT4  DNA  TAATACGACTCACTATAGGGACAGCGTCAGTCGGAGTAC  FT5  DNA  TAATACGACTCACTATAGGGACAGCGGAACCCTTATCACAG  FT6  DNA  TAATACGACTCACTATAGGGACAGCGCTGGCAAACAC  FT7  DNA  TAATACGACTCACTATAGGGACAGCGAAAAGTTTCGCTGAATTGG  FT8  DNA  TAATACGACTCACTATAGGGACAGCGAGCCACTGC  FT9  DNA  TAATACGACTCACTATAGGGACAGCGAAGC  FT10  DNA  TAATACGACTCACTATAGGGACAGCGAGAG  LP1 LT1  RNA  rGrCrGrGrUrGrGrUrCrCrUrUrArGrCrC  LT1+1 RNA  rUrGrCrGrGrUrGrGrUrCrCrUrUrArGrCrC  LT1+2 RNA  rArUrGrCrGrGrUrGrGrUrCrCrUrUrArGrCrC  LT1+3 RNA  rArArUrGrCrGrGrUrGrGrUrCrCrUrUrArGrCrC  LT1+4 RNA  rGrArArUrGrCrGrGrUrGrGrUrCrCrUrUrArGrCrC  LT1+5 RNA  rGrGrArArUrGrCrGrGrUrGrGrUrCrCrUrUrArGrCrC  LT1+6 RNA  rCrGrGrArArUrGrCrGrGrUrGrGrUrCrCrUrUrArGrCrC  LT1+7 RNA  rGrCrGrGrArArUrGrCrGrGrUrGrGrUrCrCrUrUrArGrCrC  LT1+8 RNA  rUrGrCrGrGrArArUrGrCrGrGrUrGrGrUrCrCrUrUrArGrCrC  LT2  DNA  GCGGUGGUCCUUAGCC  ME1  DNA  mCmCTTAGCCAAAAAAGGACAGCGAGCTC  ME2  DNA  mCmCTTAGCCAAAAAAGGACAGCGTGG  ME3  DNA  mCmC TTAGCCAAAAAAGGACAGCGGATTTATCC  ME4  DNA  mCmCTTAGCCAAAAAAGGACAGCGCG  ME5  DNA  same as ME4 ME6  DNA  mCmCTTAGCCAAAAAAGGACAGCGAGACC  ME7  DNA  mCmCTTAGCCAAAAAAGGACAGCGCC  ME8  DNA  mCmCTTAGCCAAAAAAGGACAGCGGG  ME9  DNA  mCmC TTAGCCAAAAAAGGACAGCGCC  ME10  DNA  mCmC TTAGCCAAAAAAGGACAGCGCAG  ME1-1 DNA  mCmUT AGC CAA AAA AGG ACA GCG AGC TCA GTC  ME1-2 DNA  mUmUA GCC AAA AAA GGA CAG CGA GCT CAG TCT G  ME1-A DNA  mUmCTTAGCCAAAAAAGGACAGCGAGCTC  ME1-C DNA  mGmCTTAGCCAAAAAAGGACAGCGAGCTC  ME1-U DNA  mAmCTTAGCCAAAAAAGGACAGCGAGCTC  OH1  RNA  rArUrUrCrCrGrCrA  PCR1  DNA  CGGTAGGTCCCTTAGCCAAAAAAGG  PCR2  DNA  TAATACGACTCACTATAGACTCACTGACACAGATCCACTCAC   PS1  DNA  GTTCAGAGTTCTACAGTCCGACGATCCGGTAGGTCCCTTAGCCAAA  AAAGG  PS2  DNA  AGACGTGTGCTCTTCCGATCTACTCACTGACACAGATCCACTCAC  PS3  DNA  GTTCAGAGTTCTACAGTCCGACGATC  PS4  DNA  AGACGTGTGCTCTTCCGATCT  RQ1  DNA  GTGCGGAATGCGGTGGT  RQ2  DNA  GCCTTAGCCAAAAAAGGACAGCG  RT1  DNA  CGGTAGGTCCCTTAGCCAAAAAAGGACAGCG  RT2  DNA  GTGCGGAATGCGGTGGTCCTT   SL1  DNA   CGGTAGGTCCCTTAGCCAAAAAAGGACAGCGNNNNNNN  NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCGCT  GTCCGTGAGTGGATCTGTGTCAGTGAGTCTATAGTGAGT  CGTATTA  TT1  DNA  mGmGACAGCGAGCTCAGTCTGC  TT2  DNA  mGmGACAGCGTGGTTCCGC  TT3  DNA  mGmGACAGCGGATTTATCCCAATTCTCTG  TT4  DNA  mGmGACAGCGCGGCTTCC  TT5  DNA  mGmGACAGCGCGCTTAGGCTTAC  TT6  DNA  mGmGACAGCGAGACCGCC  TT7  DNA  mGmGACAGCGCCACTTCACG  TT8  DNA  mGmGACAGCGGGGTGAGCAATTAC  TT9  DNA  mGmGACAGCGCCGTTTCCTC  TT10 DNA mGmGACAGCGCAGTTCTGTTCTGC Table S3 . Sequences used in this study.
